CoChat

Design and Synthesis of a Highly Selective and In Vivo-Capable Inhibitor of the Second Bromodomain of the Bromodomain and Extra Terminal Domain Family of Proteins

Open access
Preston, Alex, Atkinson, Stephen, Bamborough, Paul, Chung, Chun-wa, Craggs, Peter D., Gordon, Laurie, Grandi, Paola, Gray, James R. J., Jones, Emma J., Lindon, Matthew, Michon, Anne-Marie, Mitchell, Darren J., Prinjha, Rab K., Rianjongdee, Francesco, Rioja, Inmaculada, Seal, Jonathan, Taylor, Simon, Wall, Ian, Watson, Robert J., Woolven, James, Demont, Emmanuel H · 2020 · Journal of Medicinal Chemistry
Cited by 57

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Abstract Pan-bromodomain and extra terminal domain (BET) inhibitors interact equipotently with the eight bromodomains of the BET family of proteins and have shown profound efficacy in a number of in vitro phenotypic assays and in vivo pre-clinical models in inflammation or oncology. A number of these inhibitors have progressed to the clinic where pharmacology-driven adverse events have been reported. To better understand the contribution of each domain to their efficacy and improve their safety profile, selective inhibitors are required. This article discloses the profile of GSK046, also known as iBET-BD2, a highly selective inhibitor of the second bromodomains of the BET proteins that has undergone extensive pre-clinical in vitro and in vivo characterization.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.0c00605

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 57

Metadata

Authors
Preston, A., Atkinson, S., Bamborough, P., Chung, C.-W., Craggs, P. D., Gordon, L., Grandi, P., Gray, J. R. J., Jones, E. J., Lindon, M., Michon, A.-M., Mitchell, D. J., Prinjha, R. K., Rianjongdee, F., Rioja, I., Seal, J., Taylor, S., Wall, I., Watson, R. J., Woolven, J., & Demont, E. H.
Venue
Journal of Medicinal Chemistry
Published
2020-07-21
Volume
63
Issue
17
Pages
9070-9092
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W3045152887
Cited by
57
References
5
FWCI
2.63
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Design and Synthesis of a Highly Selective and In Vivo-Capable Inhibitor of the Second Bromodomain of the Bromodomain and Extra Terminal Domain Family of Proteins. https://app.cochat.ai/papers/10.1021/acs.jmedchem.0c00605
The paper
Preston, A., Atkinson, S., Bamborough, P., Chung, C.-W., Craggs, P. D., Gordon, L., Grandi, P., Gray, J. R. J., Jones, E. J., Lindon, M., Michon, A.-M., Mitchell, D. J., Prinjha, R. K., Rianjongdee, F., Rioja, I., Seal, J., Taylor, S., Wall, I., Watson, R. J., . . . Demont, E. H. (2020). Design and Synthesis of a Highly Selective and In Vivo-Capable Inhibitor of the Second Bromodomain of the Bromodomain and Extra Terminal Domain Family of Proteins. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.0c00605

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.